Experimental AMD drug shows promise in phase 1 study.Published in:Ocular Surgery News, 2008, v. 26, n. 6, p. 50By:Kronemyer, BobPublication type:Article
Deal watch: Alcon licenses complement pathway inhibitor for macular degeneration.Published in:Nature Reviews Drug Discovery, 2009, v. 8, n. 12, p. 922, doi. 10.1038/nrd3063Publication type:Article